• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Claudins 7 和 18 在胰腺导管腺癌中的表达:与分化特征的关联。

Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation.

机构信息

Department of Pathology and Forensic Medicine, Institute of Clinical Medicine, School of Medicine, University of Eastern Finland, Cancer Center of Eastern Finland, Kuopio, Finland.

出版信息

J Clin Pathol. 2012 May;65(5):431-6. doi: 10.1136/jclinpath-2011-200400. Epub 2012 Mar 6.

DOI:10.1136/jclinpath-2011-200400
PMID:22396552
Abstract

AIM

This study was undertaken to evaluate the expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma.

METHODS AND RESULTS

Material tested included 111 operated samples and 47 additional biopsy samples consisting of 26 cases of pancreatitis, 3 cases of pancreatic intraepithelial neoplasia and 18 ductal adenocarcinomas. Samples were stained with antibodies to claudins 7 and 18 and analysed for membranous and cytoplasmic expression. Membrane bound claudin 7 and 18 expression was detected in 62 of 105 (59%) and 78 of 111 (70%) cases, respectively. Membrane bound claudin 7 and 18 were associated with large or intermediate neoplastic ducts (p=0.01, p=0.002, respectively). Well differentiated pancreatic adenocarcinomas displayed more cases with membrane bound claudin 7 or 18 immunopositivity (p=0.003, p=0.03, respectively). All pancreatic intraepithelial neoplasias studied expressed membrane bound claudin 18. Membrane bound claudin 7 or 18 positivity was not associated with survival (p=0.17, p=0.98). In the biopsy cases membrane bound claudin 18 had 100% specificity and 51% sensitivity for a tumour marker.

CONCLUSION

Claudin 7 and 18 expression is related to gland size of neoplastic cells and is especially found in tumours with intermediate and large ducts and well differentiated tumours. Membrane bound claudin 18, when present, is a useful marker for diagnosis of pancreatic cancer. Claudins 7 and 18 were not associated with patient survival or spread of tumours.

摘要

目的

本研究旨在评估紧密连接蛋白 7 和 18 在胰腺导管腺癌中的表达。

方法和结果

检测的材料包括 111 例手术样本和 47 例额外的活检样本,其中包括 26 例胰腺炎、3 例胰腺上皮内瘤变和 18 例导管腺癌。用抗紧密连接蛋白 7 和 18 的抗体对样本进行染色,并分析其膜和细胞质表达。在 105 例中的 62 例(59%)和 111 例中的 78 例(70%)分别检测到膜结合紧密连接蛋白 7 和 18 的表达。膜结合紧密连接蛋白 7 和 18 与大或中等大小的肿瘤导管相关(p=0.01,p=0.002)。分化良好的胰腺腺癌显示出更多的膜结合紧密连接蛋白 7 或 18 免疫阳性病例(p=0.003,p=0.03)。所有研究的胰腺上皮内瘤变均表达膜结合紧密连接蛋白 18。膜结合紧密连接蛋白 7 或 18 的阳性与生存无关(p=0.17,p=0.98)。在活检病例中,膜结合紧密连接蛋白 18 的肿瘤标志物特异性为 100%,敏感性为 51%。

结论

紧密连接蛋白 7 和 18 的表达与肿瘤细胞的腺体大小有关,特别是在具有中等和大导管以及分化良好的肿瘤中发现。膜结合紧密连接蛋白 18 的存在是诊断胰腺癌的有用标志物。紧密连接蛋白 7 和 18 与患者生存或肿瘤扩散无关。

相似文献

1
Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation.Claudins 7 和 18 在胰腺导管腺癌中的表达:与分化特征的关联。
J Clin Pathol. 2012 May;65(5):431-6. doi: 10.1136/jclinpath-2011-200400. Epub 2012 Mar 6.
2
Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.Claudin-1和Claudin-4在胰腺导管内乳头状黏液性肿瘤中的不同表达模式。
Pathol Int. 2005 Feb;55(2):63-9. doi: 10.1111/j.1440-1827.2005.01793.x.
3
[Claudin expression in different pancreatic cancers and its significance in differential diagnostics].[不同胰腺癌中紧密连接蛋白的表达及其在鉴别诊断中的意义]
Magy Onkol. 2009 Sep;53(3):273-8. doi: 10.1556/MOnkol.53.2009.3.7.
4
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).导管腺癌和胰腺上皮内瘤变(PanIN)中细胞周期和增殖标志物的差异表达。
Pathology. 2010 Apr;42(3):229-34. doi: 10.3109/00313021003631379.
5
Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.异位胰腺中的胰腺上皮内瘤变:胰腺导管腺癌进展模型的证据
Am J Surg Pathol. 2007 Aug;31(8):1191-5. doi: 10.1097/PAS.0b013e31806841e1.
6
Immunohistochemical analysis of claudin expression in pancreatic cystic tumors.免疫组化分析在胰腺囊性肿瘤中 Claudin 的表达。
Oncol Rep. 2011 Apr;25(4):971-8. doi: 10.3892/or.2011.1132. Epub 2011 Jan 3.
7
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.通过全基因组表达微阵列鉴定的胰腺导管腺癌新型上皮和新型基质标志物的免疫组织化学验证:海胆丝状肌动蛋白同源物和热休克蛋白47
Am J Clin Pathol. 2002 Jul;118(1):52-9. doi: 10.1309/3PAM-P5WL-2LV0-R4EG.
8
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.纤维母细胞生长因子受体 4 在高级别胰腺上皮内瘤变和胰腺导管腺癌中的过表达。
Int J Oncol. 2011 Jan;38(1):133-43.
9
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.MUC4在胰腺上皮内瘤变中表达逐渐增加。
Am J Clin Pathol. 2002 May;117(5):791-6. doi: 10.1309/7Y7N-M1WM-R0YK-M2VA.
10
MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.通过细针穿刺获取的胰腺导管癌中MUC1和MUC2的表达
Cancer. 2003 Dec 25;99(6):365-71. doi: 10.1002/cncr.11857.

引用本文的文献

1
CAR T cell therapies in gastrointestinal cancers: current clinical trials and strategies to overcome challenges.胃肠道癌症中的嵌合抗原受体T细胞疗法:当前临床试验及克服挑战的策略
Nat Rev Gastroenterol Hepatol. 2025 Apr 14. doi: 10.1038/s41575-025-01062-y.
2
Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma.Claudin-18.2在肝内胆管癌中的预后作用
Virchows Arch. 2025 Mar 28. doi: 10.1007/s00428-025-04081-x.
3
Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy.
Claudin 18(43-14A克隆体)在胰腺导管腺癌中的表达:评估zolbetuximab治疗的潜在临床生物标志物
Transl Oncol. 2025 May;55:102362. doi: 10.1016/j.tranon.2025.102362. Epub 2025 Mar 20.
4
Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases.紧密连接蛋白家族在肝胆胰疾病中的表达及靶向应用
J Hepatocell Carcinoma. 2024 Sep 25;11:1801-1821. doi: 10.2147/JHC.S483861. eCollection 2024.
5
Claudins in Cancer: A Current and Future Therapeutic Target.紧密连接蛋白在癌症中的作用:当前和未来的治疗靶点。
Int J Mol Sci. 2024 Apr 24;25(9):4634. doi: 10.3390/ijms25094634.
6
Claudin18.2 in Advanced Gastric Cancer.Claudin18.2与晚期胃癌
Cancers (Basel). 2023 Dec 7;15(24):5742. doi: 10.3390/cancers15245742.
7
Expression patterns of claudins in cancer.紧密连接蛋白在癌症中的表达模式。
Heliyon. 2023 Oct 29;9(11):e21338. doi: 10.1016/j.heliyon.2023.e21338. eCollection 2023 Nov.
8
Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression.Claudin-18过表达的切除性胰腺导管腺癌患者的临床病理特征及预后
J Clin Med. 2023 Aug 19;12(16):5394. doi: 10.3390/jcm12165394.
9
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications.靶向CLDN18.2治疗胃肠道癌症:新药与新适应症
Front Oncol. 2023 Mar 10;13:1132319. doi: 10.3389/fonc.2023.1132319. eCollection 2023.
10
Claudin and pancreatic cancer.紧密连接蛋白与胰腺癌
Front Oncol. 2023 Mar 7;13:1136227. doi: 10.3389/fonc.2023.1136227. eCollection 2023.